Evidence map›Paper›PMID 28516088›Full record

ArticleJournal of fungi (Basel, Switzerland)2017

The

Christopher G Pierce, Taissa Vila, Jesus A Romo, Daniel Montelongo-Jauregui, Gina Wall, Anand Ramasubramanian, Jose L Lopez-Ribot

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Article
  2. Review
  3. Understanding the Effect of Propolis and Its Derivatives AgainstJournal of fungi (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. OvercomingFrontiers in antibiotics · 2026
    Review
  9. A Cross-Sectional Study to DetermineBioMed research international · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Potent anti-biofilm properties of plumbagin against fluconazole-resistantJournal of traditional and complementary medicine · 2025
    Article
  16. [Low-intensity pulsed ultrasound combined with nystatin treatment synergistically inhibits vaginalNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  17. Frontiers in microbiology · 2025
    Article
  18. Article
  19. Recent innovations and challenges in the treatment of fungal infections.Frontiers in cellular and infection microbiology · 2025
    Review
  20. The hypoxic microenvironment ofFrontiers in immunology · 2025
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher G PierceDepartment of Biology, University of the Incarnate Word, San Antonio, TX 78209, USA.
Taissa VilaDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78294, USA.
Jesus A RomoDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78294, USA.
Daniel Montelongo-JaureguiDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78294, USA.
Gina WallDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78294, USA.
Anand RamasubramanianDepartment of Biomedical, Chemical & Materials Engineering, San José State University, San José, CA 95192, USA.
Jose L Lopez-RibotDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78294, USA.

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
Development of novel chemical series of Candida albicans biofilm inhibitorsR01AI119554 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L., MCHARDY, STANTON FURST · 2015 to 2019
$1.8M
Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI119554NIDCR NIH HHS R01 DE023510NIGMS NIH HHS R25 GM060655
6 · The paper itself

Abstract

A majority of infections caused by

Indexed as

antifungal resistancebiofilmsCandida albicanscandidiasisextracellular matrix

Identifiers

PMID28516088
PMCPMC5431293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.